| Myasthenia Gravis |
1 |
1 |
| Biologic Therapy |
0 |
0.9 |
| Muscular Atrophy |
0 |
0.94 |
| Immunoglobulin G (IgG) |
0 |
0.65 |
| Upper Respiratory Tract Infection |
0 |
0.32 |
| Muscle |
0 |
0.3 |
| Quality of Life |
0 |
0.3 |
| Receptors |
0 |
0.3 |
| Respiratory Tract |
0 |
0.3 |
| Peripheral Edema |
0 |
0.22 |
| Adherence |
0 |
0.15 |
| Best Disease |
0 |
0.15 |
| Body Mass Index |
0 |
0.15 |
| Chronic Disease |
0 |
0.15 |
| Clinical Research |
0 |
0.15 |
| Edema |
0 |
0.15 |
| Expert Testimony |
0 |
0.15 |
| Grant |
0 |
0.15 |
| Hospital |
0 |
0.15 |
| Immunoglobulin A (IgA) |
0 |
0.15 |
| Immunotherapy |
0 |
0.15 |
| Monoclonal Antibody |
0 |
0.99 |
| Plasma |
0 |
0.15 |
| Rare Diseases |
0 |
0.15 |
| Weakness |
0 |
0.15 |
| Otolaryngology |
0 |
0.13 |
| Urinary Tract Infection |
0 |
0.13 |
| Care and Maintenance of Vision |
0 |
0.06 |
| Headache |
0 |
0.06 |
| Healthcare and Medical Technology |
0 |
0.06 |
| Retinal Diseases |
0 |
0.06 |